AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 165 filers reported holding AKERO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $968 | +159.5% | 19,134 | +139.6% | 0.01% | +266.7% |
| Q2 2023 | $373 | +50.4% | 7,986 | +23.1% | 0.00% | 0.0% |
| Q1 2023 | $248 | -22.7% | 6,488 | +10.9% | 0.00% | -25.0% |
| Q4 2022 | $321 | -99.9% | 5,851 | -63.7% | 0.00% | -42.9% |
| Q3 2022 | $548,000 | +171.3% | 16,101 | -24.8% | 0.01% | +250.0% |
| Q2 2022 | $202,000 | -82.7% | 21,415 | -59.0% | 0.00% | -60.0% |
| Q3 2021 | $1,168,000 | +100.3% | 52,255 | +122.2% | 0.01% | +66.7% |
| Q2 2021 | $583,000 | -16.1% | 23,513 | -1.9% | 0.00% | -25.0% |
| Q1 2021 | $695,000 | +357.2% | 23,964 | +293.7% | 0.00% | +300.0% |
| Q2 2020 | $152,000 | -20.8% | 6,087 | -39.1% | 0.00% | 0.0% |
| Q2 2019 | $192,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $169,134,000 | 18.83% |
| venBio Partners LLC | 2,444,311 | $70,909,000 | 6.74% |
| Versant Venture Management, LLC | 617,727 | $17,920,000 | 3.49% |
| Redmile Group, LLC | 2,513,746 | $72,924,000 | 1.03% |
| Boxer Capital, LLC | 831,495 | $24,122,000 | 0.82% |
| Integral Health Asset Management, LLC | 85,000 | $2,466,000 | 0.70% |
| Vivo Capital, LLC | 673,280 | $19,532,000 | 0.69% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 32,000 | $928,000 | 0.51% |
| Cormorant Asset Management, LP | 742,549 | $21,541,000 | 0.48% |
| HHLR ADVISORS, LTD. | 1,656,673 | $48,060,000 | 0.48% |